OCCURRENCE OF CANDIDA SPECIES AS AN OPPORTUNISTIC PATHOGEN IN IMMUNOCOMPROMISED HOST AND TO STUDY THE ANTIMICROBIAL POTENTIAL OF HERBAL EXTRACTS TOWARDS THESE ISOLATES.
Abstract
It is observed that 60-90% of the patients have some underlying immune suppressive condition such as chronic steroid use,
solid organ transplantation, malignancy or human immunodeficiency virus (HIV) infection, the growing problem of mucosal
and systemic candidiasis reflects the enormous increase in the number of such patients at risk and the increased
opportunity that exists for Candida species to invade tissues normally resistant to invasion .These patients are in a state in
which the immune system's ability to fight infectious disease is compromised or entirely absent and become vulnerable to
opportunistic infections, in addition to normal infections that could affect everyone. Widespread usage of antifungal has
rapidly led to the increasing cases of drug resistance which emerges as a threat to the antifungal therapy and therefore there
is an urgent need for novel therapies against this pathogen. The use of plants as sources of pharmaceutical drugs that are
used in traditional medicine need to be tested for its antimicrobial action towards these isolates
Keywords
Full Text:
PDFReferences
Barelle C.J., Pries C.L, MacCallum DM, Gow NA, Odds FC & Brown AJ (2006) Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cell Microbiol.; 8: 961-971
Hajjeh, R. A., A. N. Sofair, L. H. Harrison, G. M. Lyon, B. A. Arthington-Skaggs, S. A. Mirza, M. Phelan, J. Morgan, W. Lee-Yang, M. A. Ciblak, L. E. Benjamin, L. Thompson Sanza, S. Huie, S. F. Yeo, M. E. Brandt, and D. W. Warnock. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42:1519-1527
Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2004. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn. Microbiol. Infect. Dis. 48:101-105
Thomas, M., Walter, T., Sasi Priya, Shakthi Paargavi, NS Priya Devi, S
Thanalakshmi. (2014). A Review of Herbs to Treat Skin Disorders in Traditional Siddha Medicine. Journal of pharma-cology and toxicological studies, vol-2(1)(on line access)
Abe S., Sato Y, Inoue S, Ishibashi H, Maruyama N, Takizawa T, Oshima H,
Yamaguchi H. (2003). Anti-Candida albicans activity of essential oils including
Lemongrass (Cymbopogon citratus) oil and its component, citral. Japanese Journal of
Medical Microbiology, vol-44(4):pp285-291.
Preethi, K.C., Kuttan, R. (2009).Wound healing activity of flower extract of Calen-dula
officinalis. Journal of Basic Clinical Physiology and Pharmacolology, vol-20: pp73-79.
Monica, H., Butnariu, C. Z., Coradini .(2012).CLE Open Access. Evaluation of
biologically active compounds from Calendula officinalis flowers using spectro-
photometry .Chemistry Central Journal, vol-6:pp35-38.
Jadhav, B.K., Khandelwal, K.R., Ketkar, A.R., Pisal, S.S.,(2004).Formulation and
evaluation of muco adhesive tablets containing Eugenol for the treatment of periodontal
diseases. Drug Development and Industrial Pharmacy, vol-30(2):pp195–203
Hättenschwiler, S., Vitousek, P.M., (2000). The role of polyphenols in terrestrial
ecosystem nutrient cycling. Trends in Ecology and evolution, vol-15(6):pp 238-243
Mahakunakorn, P., Tohda, M., Murakami, Y., Matsumot., K.,(2003).Cyto prote-ctive
and cytotoxic effects of curcumin: Dual action on H 2 O 2 induced oxidative cell damage in
NG108-15 cells. Biological & Pharmaceutical Bulletin, vol-26:pp725–728
Khan M.U., Ankur,R., Deepika,B., Shadan,A., (2011).Diverse Belongings of Calen-dula
officinalis: An Overview. International Journal of Pharmaceutical Sciences and Drug
Research,vol-3(3):pp173-177
Iqbal, H., Jameel, A., Shumaila,N., Riaz Ullah, Shabir Ahmad, Sadar Jan , and
Kamin Khan., (2012).Study on the medicinal plant Calandula officinalis. African Journal of Pharmacy and Pharmacology, vol-6(13):pp973-978.
Amoian, B., Moghadamnia, A., Mayandarani, M., Amoian, M., Mehrmanesh S
(2010). The effect of Calendula extract on the plaque index and bleeding in gingivitis.
Journal of medicinal plant research, vol-4(3):pp132-140.
Fonseca,Y.M., Catani,C.D., Vicentini,F.T., et al.,(2011) Efficacy of marigold extract-loaded formulations against UV induced oxidative stress. Journal of PharmacologicalScience, vol-100:pp2182-2193.
AraúJo, C.C. and Leon, L.L., (2001).Biological activities of Curcuma longa Memóriasdo Instituto Oswaldo Cruz ,vol 96(5):pp723-8.
Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi A, Rouabhia M, Mahdouani
K, Bakhrouf A.,( 2007). The chemical composition and biological activity of essential oil,Eugenia cryophyllata (Syzygium aromaticum): A short review. Phytotherapy Research,vol-21(6):pp501-506
Chami, N., Bennis, S., Chami.F., Aboussekhra, A., Remmal, A., (2005). Study of anti-candidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiology andImmunology, vol-20(2):pp106-11.
Minami, M., Kita, M., Nakaya, T., Yamamoto, T., Kuriyama H, Imanishi J (2003).
The inhibitory effect of essential oils on herpes simplex virus type-1 replication in vitro.
Microbiology and Immunology, vol-47(9):pp681-684.
Mohammed, J. Rashad .(2008). Effect of water Clove extract on Streptococci mutans in
comparison to chlorhexidine gluconate (A comparative in-vitro and in vivo study) Marietta
Daily Journal ,vol-5(4):pp354. (Published online)
Michael, W. and Reichling, J. (2010). Plant-microbe interactions and secondary meta-
bolites with antibacterial, antifungal and antiviral properties.2 nd edition. Annual Plant
Reviews.vol-39: Functions and Biotechnology of Plant Secondary Metabolites.
Refbacks
- There are currently no refbacks.